Category - Pharmaceuticals Market Research Report

Interferon Beta Drugs Market Size, Share & Trends Analysis Report By Product (Interferon Beta-1A, Interferon Beta-1B, Peginterferon Beta-1A), By Route of Administration (Intramuscular, Subcutaneous, Intravenous), By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Global Interferon Beta Drugs Market Size is valued at USD 3.3 Bn in 2024 and is predicted to reach USD 5.5 Bn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governme...

View Sample PDF

Viral Vector Purification Market Size, Share & Trends Analysis Report By Products Type (Kit, Prepacked Column, Resin, Cassette, Filter Plate, Capsule, Reagent), By Purification Technique Type, By Type of Viral Vector Scope, By Scale of Operation, By Region, And By Segment Forecasts, 2025-2034

Global Viral Vector Purification Market Size is valued at USD 267.5 Mn in 2024 and is predicted to reach USD 1485.2 Mn by the year 2034 at a 18.8% CAGR during the forecast period for 2025-2034. Over 1,000 cell and gene therapy-related clinical trial...

View Sample PDF

Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Drug Class (NMDA, SSRIs, Decarboxylase inhibitors, Cholinesterase Inhibitors, Immunomodulators, Dopamine Inhibitors), By Applications, Region And Segment Forecasts, 2025-2034.

Neurodegenerative Disease Market Size is valued at 44.51 Billion in 2024 and is predicted to reach 71.67 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. It is anticipated to record a CAGR of 4.3% between 2022 and ...

View Sample PDF

Antibody Drug Conjugates (ADCs) � Linker and Conjugation Technologies Market Size, Share & Trends Analysis Report, Distribution By application/end use (Oncology, Emerging Indications/Non-oncology, Research Tools), technology type (Cleavable Linkers, Non-Cleavable Linkers), customer type, and payload compatibility, By Region, Forecasts, 2025-2034

The Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market size is valued at USD 1.18 Bn in 2024 and is predicted to reach USD 4.06 Bn by the year 2034 at an 13.3% CAGR during the forecast period for 2025-2034. Key Indust...

View Sample PDF

Dark Genome Therapeutics Market, Share & Trends Analysis Report, By Indication (Cancer, Autoimmune diseases, Fibrotic diseases, Neurodegenerative Disorders), By Phases (Preclinical, Phase 1, Phase 2, Phase 3), By Region, and Segment Forecasts, 2025-2034

Global Dark Genome Therapeutics Market Size is valued at USD 2.6 Bn in 2024 and is predicted to reach USD 15.7 Bn by the year 2034 at a 20.3% CAGR during the forecast period for 2025-2034. The dark genome comprises long stretches of DNA, including g...

View Sample PDF

T-cell Engagers Market, Share & Trends Analysis Report, By Application (Therapeutic, Diagnostic/Prognostic, Research), By Technology Type (Bispecific T-cell Engagers (BiTEs), Other Bispecific Antibodies, Next-Gen Engagers), By Cancer Type (Hematologic Cancers, Solid Tumors), By End-User (Hospitals, Specialty Clinics/Outpatient Centers, Research Institutions), By Region, and Segment Forecasts, 2025-2034

T-cell Engagers Market Size is predicted to grow at a 31.6% CAGR during the forecast period for 2025-2034. T-cell engagers are a class of engineered antibodies designed to recognize and eliminate harmful cells, such as tumor cells in cancer or aut...

View Sample PDF

SERD Therapeutics Market Size, Share & Trends Analysis Report By Products (Faslodex, Elacestrant, Camizestrant (AZD9833), Giredestrant (GDC-9545), Imlunestrant (LY3484356), Other Pipeline Products), By Route of Administration, By Indication, Region, And Segment Forecasts, 2025-2034

Global SERD Therapeutics Market Size is valued at USD 1339.0 Mn in 2024 and is predicted to reach USD 2108.7 Mn by the year 2034 at a 4.8% CAGR during the forecast period for 2025-2034. Selective estrogen receptor degrader (SERD) is a type of drug w...

View Sample PDF

Keloid Treatment Market Size, Share & Trends Analysis Report By Treatment (Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, Others), By End-User, By Region, And By Segment Forecasts, 2025-2034

Global Keloid Treatment Market Size is valued at USD 3.7 Bn in 2024 and is predicted to reach USD 5.1 Bn by the year 2034 at a 3.4% CAGR during the forecast period for 2025-2034. Keloid management often requires a combination of treatments and preve...

View Sample PDF

Social Determinants of the Health Market Size, Share & Trends Analysis Report By Type (Economic Stability, Food Insecurity, Social Context, Environment, Education, Healthcare Systems), Application (Authentication, Authorization, Person-matching, Consent Management, Privacy), End-User (Payers, Providers), By Region, And By Segment Forecasts, 2025-2034

Social Determinants of the Health Market Size is valued at USD 6.56 Bn in 2024 and is predicted to reach USD 33.84 Bn by the year 2034 at a 17.9% CAGR during the forecast period for 2025-2034. Social determinants of health are the environmental co...

View Sample PDF

Nanomedicine Market Size, Share & Trends Analysis Report by Application (Therapeutics, In-Vitro Diagnostics, Drug Delivery, In-Vivo Imaging, And Implants), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles, Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & Polymer-Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Inorganic Nanoparticles, Nanoshells, Nanotubes, And Nanodevices), Region And Segment Forecasts, 2025-2034

Global Nanomedicine Market Size is valued at USD 213.4 Bn in 2024 and is predicted to reach USD 655.4 Bn by the year 2034 at a 12.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Technologica...

View Sample PDF

Pharmaceuticals

Categories